About Basking Biosciences
Basking Biosciences is a company based in Columbus (United States) founded in 2019.. Basking Biosciences has raised $89.8 million across 5 funding rounds from investors including The Ohio State University, HHS and RTW Investments. The company has 3 employees as of December 31, 2024. Basking Biosciences operates in a competitive market with competitors including Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma, Remedium Bio and 4TEEN4 Pharmaceuticals, among others.
- Headquarter Columbus, United States
- Employees 3 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Basking Biosciences, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$89.8 M (USD)
in 5 rounds
-
Latest Funding Round
$55 M (USD), Series C
Feb 01, 2024
-
Investors
The Ohio State University
& 10 more
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Basking Biosciences
Basking Biosciences has successfully raised a total of $89.8M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $55 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $55.0M
-
First Round
First Round
(01 Jun 2020)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series C - Basking Biosciences | Valuation | Arch Venture Partners | |
| Oct, 2023 | Amount | Series A - Basking Biosciences | Valuation |
investors |
|
| Dec, 2020 | Amount | Seed - Basking Biosciences | Valuation | Rev1 Ventures , Broadview Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Basking Biosciences
Basking Biosciences has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include The Ohio State University, HHS and RTW Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Basking Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Basking Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Basking Biosciences Comparisons
Competitors of Basking Biosciences
Basking Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma, Remedium Bio and 4TEEN4 Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| domain | founded_year | HQ Location |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| domain | founded_year | HQ Location |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for immune and age-related conditions are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics and diagnostics for cardiovascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Basking Biosciences
Frequently Asked Questions about Basking Biosciences
When was Basking Biosciences founded?
Basking Biosciences was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Basking Biosciences located?
Basking Biosciences is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Who is the current CEO of Basking Biosciences?
Rich Shea is the current CEO of Basking Biosciences.
Is Basking Biosciences a funded company?
Basking Biosciences is a funded company, having raised a total of $89.8M across 5 funding rounds to date. The company's 1st funding round was a Seed of $5.4M, raised on Jun 01, 2020.
How many employees does Basking Biosciences have?
As of Dec 31, 2024, the latest employee count at Basking Biosciences is 3.
What does Basking Biosciences do?
Basking Biosciences was founded in 2019 in Columbus, United States, as a biotechnology firm focused on therapeutics for ischemic stroke. Drug candidate BB-031, an RNA aptamer that inhibits von Willebrand Factor, has been shown to enable vessel recanalization. Additionally, BB-025, a sequence-specific reversal oligonucleotide, is provided to neutralize the effects of BB-031. Operations center on advancing these candidates through development stages.
Who are the top competitors of Basking Biosciences?
Basking Biosciences's top competitors include Acticor Biotech, 4TEEN4 Pharmaceuticals and Remedy Pharmaceuticals.
Who are Basking Biosciences's investors?
Basking Biosciences has 11 investors. Key investors include The Ohio State University, HHS, RTW Investments, Arch Venture Partners, and Viva BioInnovator.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.